24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Boehringer Ingelheim
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:00
Immunai signs up to $15 million research pact with Boehringer Ingelheim
15:20
AI's “English-washing” problem
15:01
From Israel’s most powerful businessman to bankruptcy proceedings
14:42
Deloitte Israel acquires Vision.bi in push to expand AI and data capabilities
More stories
Buzz
Most popular
Daily
Weekly
1
AI startup Engram raises $98 million at $600 million valuation with just 13 employees
2
Cyberbit shuts down Israeli operations, lays off local workforce
3
AppsFlyer raises over $1 billion from Google, Meta, Unity and Moloco at a $2.7 billion valuation
4
Arrow and Iron Dome makers could head to Wall Street as Israel weighs partial privatization
5
Amdocs begins cutting jobs in Israel as global layoff plan moves forward
More news
Boehringer Ingelheim
1 stories about Boehringer Ingelheim
Immunai signs up to $15 million research pact with Boehringer Ingelheim
25.06.26
|
CTech
The collaboration focuses on decoding T-cell dysfunction, a common thread linking cancer and autoimmune disorders.
